181 related articles for article (PubMed ID: 27245076)
1. Aggressive TAFRO syndrome with reversible cardiomyopathy successfully treated with combination chemotherapy.
Yasuda S; Tanaka K; Ichikawa A; Watanabe K; Uchida E; Yamamoto M; Yamamoto K; Mizuchi D; Miura O; Fukuda T
Int J Hematol; 2016 Oct; 104(4):512-8. PubMed ID: 27245076
[TBL] [Abstract][Full Text] [Related]
2. Diffuse Large B-cell Lymphoma during Corticosteroid Therapy for TAFRO Syndrome.
Ohya E; Mizutani M; Sakaguchi H; Sekine T
Intern Med; 2016; 55(19):2861-2867. PubMed ID: 27725549
[TBL] [Abstract][Full Text] [Related]
3. Successful Treatment of TAFRO Syndrome, a Variant of Multicentric Castleman's Disease, with Cyclosporine A: Possible Pathogenetic Contribution of Interleukin-2.
Konishi Y; Takahashi S; Nishi K; Sakamaki T; Mitani S; Kaneko H; Mizutani C; Ukyo N; Hirata H; Tsudo M
Tohoku J Exp Med; 2015 Aug; 236(4):289-95. PubMed ID: 26250536
[TBL] [Abstract][Full Text] [Related]
4. Clinical features and treatment of 7 Chinese TAFRO syndromes from 96 de novo Castleman diseases: a 10-year retrospective study.
Zhang Y; Suo SS; Yang HJ; Zhou XP; You LS; Yu WJ; Wang ZM; Jin J
J Cancer Res Clin Oncol; 2020 Feb; 146(2):357-365. PubMed ID: 31938902
[TBL] [Abstract][Full Text] [Related]
5. [Pseudo-adult Still's disease, anasarca, thrombotic thrombocytopenic purpura and dysautonomia: An atypical presentation of multicentric Castleman's disease. Discussion of TAFRO syndrome].
Jouvray M; Terriou L; Meignin V; Bouchindhomme B; Jourdain M; Lambert M; Lefevre G; Hachulla E; Hatron PY; Galicier L; Launay D
Rev Med Interne; 2016 Jan; 37(1):53-7. PubMed ID: 26411598
[TBL] [Abstract][Full Text] [Related]
6. [Localized Castleman's disease associated with high-grade lymphoma].
Sanz García RM; Guerra Vales JM; de Prada I; Martínez MA; Guillén Camargo V
An Med Interna; 1999 Jun; 16(6):305-7. PubMed ID: 10422302
[TBL] [Abstract][Full Text] [Related]
7. Acute Kidney Injury Caused by TAFRO Syndrome in a Chinese Patient: Efficacy of Long-Term Corticosteroids Combined with Bortezomib and Cyclophosphamide.
Xia P; Zhang L; Zou M; Zhang T; Li R; Shi X; Wang J; Qin Y; Li X; Li J; Chen L
Kidney Blood Press Res; 2020; 45(4):623-630. PubMed ID: 32492687
[TBL] [Abstract][Full Text] [Related]
8. CT findings in 11 patients with TAFRO syndrome: a variant of multicentric Castleman's disease.
Kiguchi T; Sato C; Takai K; Nakai Y; Kaneko Y; Matsuki M
Clin Radiol; 2017 Oct; 72(10):905.e1-905.e5. PubMed ID: 28629605
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment by rituximab in a patient with TAFRO syndrome with cardiomyopathy.
Hiramatsu S; Ohmura K; Tsuji H; Kawabata H; Kitano T; Sogabe A; Hashimoto M; Murakami K; Imura Y; Yukawa N; Yoshifuji H; Fujii T; Takaori-Kondo A; Mimori T
Nihon Rinsho Meneki Gakkai Kaishi; 2016; 39(1):64-71. PubMed ID: 27181237
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of aggressive HIV-associated multicentric Castleman's disease: a case report.
Flejsierowicz M; Ahmed MS; Kotov P; Cheng YC
WMJ; 2008 Jul; 107(4):191-4. PubMed ID: 18702436
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of a Caucasian case of multifocal Castleman's disease with TAFRO syndrome with a pathophysiology targeted therapy - a case report.
Tedesco S; Postacchini L; Manfredi L; Goteri G; Luchetti MM; Festa A; Gabrielli A; Pomponio G
Exp Hematol Oncol; 2015; 4(1):3. PubMed ID: 25671135
[TBL] [Abstract][Full Text] [Related]
12. High proportion of TAFRO syndrome in Thai adult Castleman's disease patients: a 10-year experience.
Owattanapanich W; Pholmoo W; Pongpruttipan T; Siritanaratkul N
Ann Hematol; 2018 Jun; 97(6):1019-1026. PubMed ID: 29464312
[TBL] [Abstract][Full Text] [Related]
13. Presentation of multicentric Castleman's disease with sicca syndrome, cardiomyopathy, palmar and plantar rash.
Kingsmore SF; Silva OE; Hall BD; Sheldon EA; Cripe LD; St Clair EW
J Rheumatol; 1993 Sep; 20(9):1588-91. PubMed ID: 8164221
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of TAFRO syndrome, a variant type of multicentric Castleman disease with thrombotic microangiopathy, with anti-IL-6 receptor antibody and steroids.
Fujiwara S; Mochinaga H; Nakata H; Ohshima K; Matsumoto M; Uchiba M; Mikami Y; Hata H; Okuno Y; Mitsuya H; Nosaka K
Int J Hematol; 2016 Jun; 103(6):718-23. PubMed ID: 26980221
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment with tacrolimus in TAFRO syndrome: two case reports and literature review.
Shirai T; Onishi A; Waki D; Saegusa J; Morinobu A
Medicine (Baltimore); 2018 Jun; 97(23):e11045. PubMed ID: 29879072
[TBL] [Abstract][Full Text] [Related]
16. [Chylothorax and chylous ascites as symptoms of Castleman's disease].
Saaresranta T; Söderström KO; Ruokonen EL
Duodecim; 1995; 111(4):348-50. PubMed ID: 8654303
[No Abstract] [Full Text] [Related]
17. Successful Treatment of TAFRO Syndrome with Tocilizumab, Prednisone, and Cyclophosphamide.
Kikuchi T; Shimizu T; Toyama T; Abe R; Okamoto S
Intern Med; 2017 Aug; 56(16):2205-2211. PubMed ID: 28781319
[TBL] [Abstract][Full Text] [Related]
18. Thrombocytopenia, Anasarca, Myelofibrosis, Renal dysfunction, and Organomegaly (TAFRO) Syndrome Initially Diagnosed as Fibromyalgia: A Case Report.
Ohta R; Sano C
Cureus; 2023 Jul; 15(7):e42514. PubMed ID: 37637539
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of twelve cases of angiofollicular lymph node hyperplasia with literature review].
Dong QM; He YJ
Ai Zheng; 2008 Jan; 27(1):101-4. PubMed ID: 18184475
[TBL] [Abstract][Full Text] [Related]
20. [Autoimmune hemolytic anemia associated with multicentric Castleman's disease with a 28-year history].
Hisatake J; Ishiyama T; Akimoto Y; Matsuda I; Hino K; Tomoyasu S; Tsuruoka N; Ota H; Kazama K
Rinsho Ketsueki; 1994 Aug; 35(8):768-73. PubMed ID: 7933564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
